Windham Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,212
| Closed | -$1.27M | – | 83 |
|
|
2023
Q4 | $1.27M | Buy |
14,212
+2
| +0% | +$179 | 0.47% | 47 |
|
|
2023
Q3 | $1.04M | Hold |
14,210
| – | – | 0.42% | 51 |
|
|
2023
Q2 | $1.18M | Hold |
14,210
| – | – | 0.46% | 48 |
|
|
2023
Q1 | $1.08M | Buy |
14,210
+710
| +5% | +$54.1K | 0.43% | 48 |
|
|
2022
Q4 | $1.12M | Hold |
13,500
| – | – | 0.43% | 39 |
|
|
2022
Q3 | $1.07M | Hold |
13,500
| – | – | 0.4% | 42 |
|
|
2022
Q2 | $1M | Hold |
13,500
| – | – | 0.24% | 44 |
|
|
2022
Q1 | $1.21M | Hold |
13,500
| – | – | 0.26% | 41 |
|
|
2021
Q4 | $1.51M | Hold |
13,500
| – | – | 0.31% | 41 |
|
|
2021
Q3 | $1.7M | Hold |
13,500
| – | – | 0.35% | 38 |
|
|
2021
Q2 | $1.83M | Hold |
13,500
| – | – | 0.37% | 35 |
|
|
2021
Q1 | $1.83M | Hold |
13,500
| – | – | 0.39% | 35 |
|
|
2020
Q4 | $1.9M | Hold |
13,500
| – | – | 0.41% | 33 |
|
|
2020
Q3 | $1.5M | Hold |
13,500
| – | – | 0.34% | 36 |
|
|
2020
Q2 | $1.51M | Hold |
13,500
| – | – | 0.34% | 32 |
|
|
2020
Q1 | $1.05M | Hold |
13,500
| – | – | 0.25% | 35 |
|
|
2019
Q4 | $1.28M | Hold |
13,500
| – | – | 0.28% | 44 |
|
|
2019
Q3 | $1.03M | Hold |
13,500
| – | – | 0.23% | 39 |
|
|
2019
Q2 | $1.18M | Hold |
13,500
| – | – | 0.2% | 35 |
|
|
2019
Q1 | $1.22M | Buy |
+13,500
| New | +$1.22M | 0.2% | 35 |
|